Fulvio Basolo

Active 1990–2024

128
Papers
18,457
Citations
81
h-index
127
i10-index

Citations

Citations per year for Fulvio Basolo1991: 3 citations1992: 2 citations1993: 2 citations1994: 7 citations1995: 14 citations1996: 19 citations1997: 25 citations1998: 44 citations1999: 30 citations2000: 65 citations2001: 47 citations2002: 69 citations2003: 50 citations2004: 75 citations2005: 90 citations2006: 154 citations2007: 98 citations2008: 113 citations2009: 148 citations2010: 148 citations2011: 169 citations2012: 174 citations2013: 171 citations2014: 106 citations2015: 125 citations2016: 158 citations2017: 159 citations2018: 107 citations2019: 507 citations2020: 503 citations2021: 464 citations2022: 371 citations2023: 249 citations2024: 398 citations2025: 149 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,370 citing papers, 24.8% of this breakdownItaly: 800 citing papers, 14.5% of this breakdownChina: 596 citing papers, 10.8% of this breakdownGermany: 211 citing papers, 3.8% of this breakdownSouth Korea: 208 citing papers, 3.8% of this breakdownUnited Kingdom: 204 citing papers, 3.7% of this breakdownFrance: 190 citing papers, 3.4% of this breakdownJapan: 177 citing papers, 3.2% of this breakdownCanada: 148 citing papers, 2.7% of this breakdownSpain: 116 citing papers, 2.1% of this breakdownAustralia: 114 citing papers, 2% of this breakdownSwitzerland: 109 citing papers, 2% of this breakdown
0%24.8%Other 23.2%

Fields

  • Medicine78.4%
  • Biochemistry, Genetics and Molecular Biology16.6%
  • Immunology and Microbiology2.2%
  • Computer Science0.5%
  • Engineering0.3%
  • Neuroscience0.3%
  • Other1.7%

Topics

  • Thyroid Cancer Diagnosis and Treatment18.7%
  • Thyroid and Parathyroid Surgery7%
  • Thyroid Disorders and Treatments6.1%
  • Cancer-related Molecular Pathways3%
  • Head and Neck Anomalies2.4%
  • BRCA gene mutations in cancer2.3%
  • Other60.5%

Coauthors

All papers

Open in search
  1. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ronald Ghossein - JAMA Oncology 2016 cited by 1,384

  2. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

    Authors: , , , , , , , , , , , , - Nature Reviews Endocrinology 2017 cited by 488

  3. Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing

    Authors: , , , , , , , , , , , - iScience 2019 cited by 229

  4. The 5th edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma

    Authors: , , , - Endocrine 2023 cited by 102

  5. BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

    Authors: , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2003 cited by 1,054

  6. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2019 cited by 159

  7. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2009 cited by 561

  8. Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Endocrinological Investigation 2018 cited by 216

  9. Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders

    Authors: , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2004 cited by 537

  10. Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study

    Authors: , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2007 cited by 528

  11. New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations

    Authors: , , , , , , , , , , , , , , , - Journal of Medical Genetics 2016 cited by 89

  12. Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like

    Authors: , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2019 cited by 81

  13. Italian consensus for the classification and reporting of thyroid cytology

    Authors: , , , , , , , , , , - Journal of Endocrinological Investigation 2014 cited by 417

  14. Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study

    Authors: , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 321

  15. Mast cells have a protumorigenic role in human thyroid cancer

    Authors: , , , , , , , , , , , - Oncogene 2010 cited by 217

  16. Role ofNRASmutations as prognostic and predictive markers in metastatic colorectal cancer

    Authors: , , , , , , , , , , , , , , , , - International Journal of Cancer 2014 cited by 160

  17. Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy

    Authors: , , , , , , , , , , , , , , - JAMA Ophthalmology 2018 cited by 91

  18. Indeterminate Thyroid Nodules: From Cytology to Molecular Testing

    Authors: , , , , - Diagnostics 2023 cited by 23

  19. Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis

    Authors: , , , , - Thyroid 2023 cited by 18

  20. BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study

    Authors: , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 527

  21. TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study

    Authors: , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2012 cited by 236

  22. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with l-thyroxine

    Authors: , , , , , , , , , , , - Endocrine Related Cancer 2011 cited by 174

  23. RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

    Authors: , , , , , , , , , , , , , , - Clinical Endocrinology 2010 cited by 128

  24. Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer

    Authors: , , , , , , , , , , , , - Thyroid 2012 cited by 75